Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. - Wikidata - awgldk - TriplyDB

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide.

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide.

http://www.wikidata.org/entity/Q44187794

about

Statins and dementia Statins, cognition, and dementia—systematic review and methodological commentary Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice.The effects of cholesterol on learning and memory.ACAT inhibition and amyloid beta reduction.Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population Molecular mechanisms underlying the effects of statins in the central nervous system.The effects of cardiovascular risk factors on cognitive compromise Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memory Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism.Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease.Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease Statins--a cure-all for the brain?Cholesterol and apolipoprotein E in Alzheimer's disease.Cholesterol homeostasis and the pathophysiology of Alzheimer's disease.Neuroinflammation: a potential therapeutic target.Cholesterol: its regulation and role in central nervous system disorders.Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function.Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.Alzheimer's disease: cholesterol, membrane rafts, isoprenoids and statins Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells.Oxysterols in biological systems: the gastrointestinal tract, liver, vascular wall and central nervous system.Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider.Red mold fermented products and Alzheimer's disease: a review.Brain cholesterol metabolism, oxysterols, and dementia.Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease.Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.Cholesterol impairment contributes to neuroserpin aggregation.The effect of simvastatin treatment on the amyloid precursor protein and brain cholesterol metabolism in patients with Alzheimer's disease.Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones.Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.Functional relationships between serum total cholesterol levels, executive control, and sustained attention.Simvastatin enhances learning and memory independent of amyloid load in mice.

P2860

Q22252608-8573AABB-837F-42DA-92F4-F2B2BEDDCEB1 Q26852778-3807AF1C-17BF-4124-BEC3-9A74F7AC7F5A Q27009984-AED63FE4-B1C4-48F6-B766-2BD8C42BD3B2 Q28504715-9E878260-52FD-4DD6-9FC2-938DBBC8EE5F Q30417962-46A21237-783B-401A-BF24-A9A3B4D834D4 Q33665597-927CE222-AB37-47EE-A03E-669EB597B50C Q33976829-555783A0-D45D-4360-928B-B58389C5010E Q34052308-307D7D5D-2145-4B50-A3A6-893D1EF098CF Q34471418-96074F35-EC60-42EC-8969-F7742536BE85 Q34685463-14B7BBE0-B385-4611-8ECC-1FAF4A5FBEA4 Q34976702-859E31CF-2B27-469A-9E28-6DBF6F99993E Q34990621-0DCAFD56-449E-4EF8-B005-B879A4EF809F Q35485586-38CB459E-856B-45B5-A813-8A8FAEF2837D Q35807320-5C9F9BC7-EA98-4D8A-AADE-3E97D72CD854 Q35947072-E1031585-285E-4076-8D5C-D06762B6DFCA Q35978920-82876FDB-233D-4815-ADB4-D8E10C6862BA Q36085649-5BE1F7BB-C741-4A06-B49D-CDEF0E463856 Q36103897-F3882331-EC7C-4975-8CDA-F6055CAE390C Q36106865-CCC504D1-C5F7-4321-BD31-C4F487569BBA Q36268282-A70127DC-0F16-4E2D-9D29-9ACAB7F7D73A Q36355194-C622D463-85A1-4619-B71C-0CA6BC27EC2F Q36546479-AA3E7B13-524A-4920-A5AF-74C4FBA2AD18 Q36546521-A13E25EC-6137-4F1B-AF06-B07C510B00DF Q36830139-5C292363-BB79-431F-8A91-5297312BD376 Q36884234-72011B95-4FE5-42F5-B4F9-5345AFC06AD0 Q36959256-8B679FDA-D0A6-42B0-9429-D4F774157C4A Q37211751-4510838D-1098-4848-B4D9-0D5610A08846 Q37337494-81956A7B-6FF5-416C-B59B-0B7019C7E99F Q37638753-5143EB9D-0228-4973-94C7-B650D528FE78 Q37801334-DE3B73B6-4316-4B94-9746-9E1E0CB43D1D Q37891842-0D9C566C-39EB-498A-92EE-96D07C65D960 Q38053046-F7CD832E-A5C1-4209-B9FE-27E7DD220FB3 Q38119019-BF7F6895-BB79-4C52-AF50-DF5691237797 Q40593829-6764312F-4333-41DF-81AF-51A1CB1E5761 Q42034639-F6428793-396E-4A88-A0F2-37815B53150C Q42651492-69AE9F29-3852-4A10-94E9-2D1F318BDC0C Q45301947-9A2129C1-6916-4A9D-9D56-D7A9B92EA6C5 Q46529505-43456133-C75B-41F5-99DB-6F0E995F415A Q46568945-1A2D9E7A-C703-448A-A705-0C598E730EC2 Q48325996-0386D99D-D189-40BE-9ECD-3D799E691D4B

P2860

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide.

http://www.wikidata.org/entity/Q44187794

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Effects of statins on human ce ...... of Alzheimer amyloid peptide.

@en

Effects of statins on human ce ...... of Alzheimer amyloid peptide.

@nl

type

label

Effects of statins on human ce ...... of Alzheimer amyloid peptide.

@en

Effects of statins on human ce ...... of Alzheimer amyloid peptide.

@nl

prefLabel

Effects of statins on human ce ...... of Alzheimer amyloid peptide.

@en

Effects of statins on human ce ...... of Alzheimer amyloid peptide.

@nl

P1433

Q44187794-232C39B5-47E7-40F1-A48F-38E30496EFA5

P1476

Q44187794-8C41B361-357D-4267-AE21-8B77E6025DF8

P2093

Q44187794-2EB6B9E2-2262-425A-AD8A-9F836D3F6DB5

Q44187794-594EED78-18A5-4D5E-A2BB-45E1883671A0

Q44187794-812C8D39-88CE-42C7-9AB1-D965AE3C9285

Q44187794-96FFBECB-76A3-4D5E-898F-BD45729FACB4

Q44187794-9F6F079E-3B71-49F7-8E77-8FA5D59FE601

Q44187794-A6589465-1F97-410D-B1C9-89DA40187792

Q44187794-AFD332F5-CA54-4A4A-8F73-108DD9F4333E

Q44187794-CFF23D26-0132-4C56-994D-F4AC66CA58C5

Q44187794-D235943A-2358-483B-9824-BCF80647F524

Q44187794-ED639506-38BE-4E22-9BCE-8BA138479542

P304

Q44187794-951161BB-3549-48E2-B2E7-77CA275AB15D

P31

Q44187794-C0718602-94DA-44B8-9818-A33BC212F685

P356

Q44187794-E4954931-4145-491A-A137-A2BC7D0650EC

P407

Q44187794-8E0F4E8C-69DE-42C1-A101-3040F8FB178E

P433

Q44187794-FC76396D-C0AF-423F-ACFD-76153C5E1D57

P478

Q44187794-066AFBEF-838C-472D-A8F2-DC93686DA81B

P50

Q44187794-B7B087C2-F8E1-4909-848A-8C40452BCF4B

P577

Q44187794-2C25C2C1-E586-4B03-8DA3-94C88616FCA3

P698

Q44187794-41ECFA7A-F6E9-4939-8B0C-4289BBC45F51

P921

Q44187794-C9C7E1CC-EF8A-46B8-A6DA-A2D2348A536F

P356

P1433

P1476

Effects of statins on human ce ...... of Alzheimer amyloid peptide.

@en

P2093

Bertsch T

http://www.w3.org/2001/XMLSchema#string

Brechtel K

http://www.w3.org/2001/XMLSchema#string

Kuehl S

http://www.w3.org/2001/XMLSchema#string

Lütjohann D

http://www.w3.org/2001/XMLSchema#string

Muehlhauser F

http://www.w3.org/2001/XMLSchema#string

Ragoschke A

http://www.w3.org/2001/XMLSchema#string

Stroick M

http://www.w3.org/2001/XMLSchema#string

Von Bergmann K

http://www.w3.org/2001/XMLSchema#string

Walter J

http://www.w3.org/2001/XMLSchema#string

Walter S

http://www.w3.org/2001/XMLSchema#string

P304

1257-1258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.59.8.1257

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Klaus Fassbender

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12391360

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease